Project Number 20141106-Sneddon-2014 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2014 View Full Project Details for FTD Trafficking Assays and Compound Screening: Inhibiting Sortilin-dependent progranulin endocytosis. Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 2. Identification and Validation of Novel Targets Researcher and Organization Principal Investigator Sneddon, Scott Principal Investigator First Name Scott Principal Investigator Last Name Sneddon Awardee Organization Sharp Edge Labs, Inc Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement Preclinical RFP FY Overall Cost $188,800 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
